ROSSI DINO A — SEC insider filings
SEC reporting owner CIK 1209059. 12 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2020-08-07 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 3 filings — 83,950 shares, $16,511,619 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 40,000 shares @ $83.25 ($3,329,972) in Krystal Biotech, Inc., filed 2023-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | Director | 12 | — | 11 legs · 83,950 sh · $16,511,619 | 13 |
Insider filings — ROSSI DINO A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Krystal Biotech, Inc. (KRYS) | Gift (G): 3,500 @ $0 | EDGAR |
| 2026-09-16 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Krystal Biotech, Inc. (KRYS) | Gift (G): 3,691 @ $0 · Sale (S): 341 @ $325.60 · Sale (S): 2,287 @ $326.60 · Sale (S): 5,226 @ $327.39 · Sale (S): 1,687 @ $328.52 · Sale (S): 7,428 @ $329.60 · +3 more | EDGAR |
| 2026-02-23 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 18,950 @ $8.79 · Sale (S): 8,116 @ $260.49 · Sale (S): 10,834 @ $262.10 · Option exercise (M): 18,950 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | Krystal Biotech, Inc. (KRYS) | Gift (G): 5,000 @ $0 | EDGAR |
| 2024-07-01 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-07-03 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 6,800 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 40,000 @ $83.25 | EDGAR |
| 2022-07-01 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 6,800 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 6,800 (derivative) @ $0 | EDGAR |
| 2020-08-07 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 6,800 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1209059 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs